Johnson & Johnson (JNJ)
USD 156.12
(1.07%)
USD 156.12
(1.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 23.72 Billion USD | 7.16% |
| 2022 | 27.17 Billion USD | 8.27% |
| 2021 | 30.92 Billion USD | 15.24% |
| 2020 | 27.49 Billion USD | 9.27% |
| 2019 | 28.27 Billion USD | -1.89% |
| 2018 | 28.1 Billion USD | 13.68% |
| 2017 | 24.53 Billion USD | -8.51% |
| 2016 | 24.91 Billion USD | 14.0% |
| 2015 | 22.11 Billion USD | -10.76% |
| 2014 | 25.03 Billion USD | 9.1% |
| 2013 | 23.16 Billion USD | 7.38% |
| 2012 | 17.95 Billion USD | -6.52% |
| 2011 | 16.04 Billion USD | 17.78% |
| 2010 | 20.34 Billion USD | -2.95% |
| 2009 | 18.96 Billion USD | -4.05% |
| 2008 | 20.19 Billion USD | -11.6% |
| 2007 | 16.35 Billion USD | 27.27% |
| 2006 | 15.77 Billion USD | 1.04% |
| 2005 | 15.61 Billion USD | 3.94% |
| 2004 | 15.02 Billion USD | 13.16% |
| 2003 | 13.27 Billion USD | 12.26% |
| 2002 | 11.82 Billion USD | 20.89% |
| 2001 | 9.78 Billion USD | 21.04% |
| 2000 | 8.08 Billion USD | 6.43% |
| 1999 | 7.59 Billion USD | 9.13% |
| 1998 | 6.95 Billion USD | 23.9% |
| 1997 | 5.61 Billion USD | 2.9% |
| 1996 | 5.45 Billion USD | 23.49% |
| 1995 | 4.41 Billion USD | 23.61% |
| 1994 | 3.57 Billion USD | 21.97% |
| 1993 | 2.93 Billion USD | 5.32% |
| 1992 | 2.78 Billion USD | 4.86% |
| 1991 | 2.65 Billion USD | 0.76% |
| 1990 | 2.63 Billion USD | 26.57% |
| 1989 | 2.08 Billion USD | 22.48% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 7.1 Billion USD | -35.3% |
| 2024 Q1 | 8.64 Billion USD | 25.26% |
| 2024 Q2 | 9.28 Billion USD | -1.99% |
| 2023 Q4 | 6.93 Billion USD | -18.44% |
| 2023 Q2 | 8.7 Billion USD | 6.33% |
| 2023 Q3 | 8.5 Billion USD | -2.3% |
| 2023 Q1 | 8.18 Billion USD | 132.24% |
| 2023 FY | - USD | 7.16% |
| 2022 Q2 | 8.5 Billion USD | 3.6% |
| 2022 Q3 | 7.57 Billion USD | -10.98% |
| 2022 Q4 | 3.52 Billion USD | -53.47% |
| 2022 FY | - USD | 8.27% |
| 2022 Q1 | 8.21 Billion USD | 48.7% |
| 2021 Q1 | 8.93 Billion USD | 222.59% |
| 2021 FY | - USD | 15.24% |
| 2021 Q4 | 5.52 Billion USD | -36.11% |
| 2021 Q3 | 8.64 Billion USD | 2.93% |
| 2021 Q2 | 8.39 Billion USD | -6.06% |
| 2020 Q2 | 5.77 Billion USD | -30.71% |
| 2020 Q3 | 7.96 Billion USD | 37.92% |
| 2020 FY | - USD | 9.27% |
| 2020 Q1 | 8.33 Billion USD | 34.0% |
| 2020 Q4 | 2.77 Billion USD | -65.23% |
| 2019 FY | - USD | -1.89% |
| 2019 Q4 | 6.22 Billion USD | -19.09% |
| 2019 Q1 | 7.21 Billion USD | 39.45% |
| 2019 Q2 | 9.18 Billion USD | 27.39% |
| 2019 Q3 | 7.69 Billion USD | -16.27% |
| 2018 Q2 | 7 Billion USD | -7.01% |
| 2018 FY | - USD | 13.68% |
| 2018 Q4 | 5.17 Billion USD | -32.06% |
| 2018 Q3 | 7.61 Billion USD | 8.73% |
| 2018 Q1 | 7.52 Billion USD | 43.25% |
| 2017 Q3 | 6.79 Billion USD | 10.81% |
| 2017 Q4 | 5.25 Billion USD | -22.71% |
| 2017 FY | - USD | -8.51% |
| 2017 Q1 | 6.77 Billion USD | 17.68% |
| 2017 Q2 | 6.13 Billion USD | -9.45% |
| 2016 FY | - USD | 14.0% |
| 2016 Q2 | 6.13 Billion USD | -5.07% |
| 2016 Q1 | 6.46 Billion USD | 13.94% |
| 2016 Q3 | 6.44 Billion USD | 4.99% |
| 2016 Q4 | 5.75 Billion USD | -10.63% |
| 2015 Q1 | 6.6 Billion USD | 65.66% |
| 2015 Q3 | 5.18 Billion USD | -23.32% |
| 2015 FY | - USD | -10.76% |
| 2015 Q4 | 5.67 Billion USD | 9.45% |
| 2015 Q2 | 6.76 Billion USD | 2.32% |
| 2014 Q2 | 6.71 Billion USD | 1.81% |
| 2014 Q4 | 3.98 Billion USD | -49.37% |
| 2014 Q3 | 7.87 Billion USD | 17.42% |
| 2014 Q1 | 6.59 Billion USD | 52.43% |
| 2014 FY | - USD | 9.1% |
| 2013 Q3 | 4.92 Billion USD | -16.52% |
| 2013 Q1 | 5.48 Billion USD | 83.42% |
| 2013 FY | - USD | 7.38% |
| 2013 Q4 | 4.32 Billion USD | -12.22% |
| 2013 Q2 | 5.9 Billion USD | 7.56% |
| 2012 FY | - USD | -6.52% |
| 2012 Q4 | 2.99 Billion USD | -44.75% |
| 2012 Q3 | 5.41 Billion USD | 56.52% |
| 2012 Q1 | 5.96 Billion USD | 42.64% |
| 2012 Q2 | 3.45 Billion USD | -42.01% |
| 2011 FY | - USD | 17.78% |
| 2011 Q4 | 4.18 Billion USD | -11.4% |
| 2011 Q3 | 4.72 Billion USD | -7.87% |
| 2011 Q2 | 5.12 Billion USD | -4.72% |
| 2011 Q1 | 5.37 Billion USD | 26.97% |
| 2010 Q3 | 4.76 Billion USD | -5.74% |
| 2010 FY | - USD | -2.95% |
| 2010 Q1 | 5.52 Billion USD | 44.6% |
| 2010 Q2 | 5.05 Billion USD | -8.65% |
| 2010 Q4 | 4.23 Billion USD | -11.03% |
| 2009 Q3 | 4.96 Billion USD | -1.82% |
| 2009 Q4 | 3.82 Billion USD | -23.02% |
| 2009 Q2 | 5.05 Billion USD | -5.46% |
| 2009 Q1 | 5.35 Billion USD | 20.22% |
| 2009 FY | - USD | -4.05% |
| 2008 Q1 | 5.49 Billion USD | 11.51% |
| 2008 FY | - USD | -11.6% |
| 2008 Q4 | 4.45 Billion USD | -10.21% |
| 2008 Q3 | 4.95 Billion USD | -1.43% |
| 2008 Q2 | 5.02 Billion USD | -8.47% |
| 2007 Q2 | 4.44 Billion USD | -17.69% |
| 2007 Q1 | 5.39 Billion USD | 37.59% |
| 2007 FY | - USD | 27.27% |
| 2007 Q4 | 4.92 Billion USD | -7.18% |
| 2007 Q3 | 5.3 Billion USD | 19.42% |
| 2006 Q4 | 3.92 Billion USD | -9.29% |
| 2006 FY | - USD | 1.04% |
| 2006 Q1 | 3.59 Billion USD | 22.46% |
| 2006 Q2 | 3.93 Billion USD | 9.41% |
| 2006 Q3 | 4.32 Billion USD | 10.05% |
| 2005 Q2 | 4.25 Billion USD | -1.32% |
| 2005 Q4 | 2.93 Billion USD | -21.04% |
| 2005 Q3 | 3.71 Billion USD | -12.56% |
| 2005 Q1 | 4.3 Billion USD | 29.22% |
| 2005 FY | - USD | 3.94% |
| 2004 Q3 | 3.85 Billion USD | -2.01% |
| 2004 Q2 | 3.93 Billion USD | 0.64% |
| 2004 Q4 | 3.33 Billion USD | -13.47% |
| 2004 FY | - USD | 13.16% |
| 2004 Q1 | 3.9 Billion USD | 53.6% |
| 2003 Q3 | 3.25 Billion USD | -21.21% |
| 2003 Q1 | 3.33 Billion USD | 29.39% |
| 2003 Q4 | 2.54 Billion USD | -21.95% |
| 2003 FY | - USD | 12.26% |
| 2003 Q2 | 4.13 Billion USD | 23.91% |
| 2002 Q4 | 2.57 Billion USD | -16.29% |
| 2002 FY | - USD | 20.89% |
| 2002 Q3 | 3.08 Billion USD | -0.8% |
| 2002 Q2 | 3.1 Billion USD | 1.6% |
| 2002 Q1 | 3.05 Billion USD | 48.83% |
| 2001 FY | - USD | 21.04% |
| 2001 Q4 | 2.05 Billion USD | -18.36% |
| 2001 Q3 | 2.51 Billion USD | -6.29% |
| 2001 Q2 | 2.68 Billion USD | 6.34% |
| 2001 Q1 | 2.52 Billion USD | 58.61% |
| 2000 Q1 | 2.23 Billion USD | 48.74% |
| 2000 Q2 | 2.25 Billion USD | 1.03% |
| 2000 Q3 | 2.13 Billion USD | -5.45% |
| 2000 Q4 | 1.59 Billion USD | -25.4% |
| 2000 FY | - USD | 6.43% |
| 1999 Q4 | 1.5 Billion USD | -25.01% |
| 1999 FY | - USD | 9.13% |
| 1999 Q1 | 2.14 Billion USD | -0.28% |
| 1999 Q2 | 2.02 Billion USD | -5.59% |
| 1999 Q3 | 2 Billion USD | -1.18% |
| 1998 FY | - USD | 23.9% |
| 1998 Q1 | 1.65 Billion USD | 54.19% |
| 1998 Q4 | 2.15 Billion USD | 38.19% |
| 1998 Q3 | 1.55 Billion USD | -2.01% |
| 1998 Q2 | 1.59 Billion USD | -3.99% |
| 1997 Q2 | 1.51 Billion USD | -5.38% |
| 1997 Q4 | 1.07 Billion USD | -24.84% |
| 1997 Q3 | 1.42 Billion USD | -5.55% |
| 1997 Q1 | 1.59 Billion USD | 51.13% |
| 1997 FY | - USD | 2.9% |
| 1996 FY | - USD | 23.49% |
| 1996 Q1 | 1.46 Billion USD | 30.52% |
| 1996 Q4 | 1.05 Billion USD | -28.66% |
| 1996 Q3 | 1.48 Billion USD | 2.35% |
| 1996 Q2 | 1.44 Billion USD | -1.23% |
| 1995 FY | - USD | 23.61% |
| 1995 Q4 | 1.12 Billion USD | 6.24% |
| 1995 Q3 | 1.05 Billion USD | -8.56% |
| 1995 Q1 | 1.2 Billion USD | 49.88% |
| 1995 Q2 | 1.15 Billion USD | -4.22% |
| 1994 Q2 | 909 Million USD | 1.79% |
| 1994 Q3 | 937 Million USD | 6.6% |
| 1994 FY | - USD | 21.97% |
| 1994 Q4 | 806 Million USD | -16.82% |
| 1994 Q1 | 893 Million USD | 47.36% |
| 1993 FY | - USD | 5.32% |
| 1993 Q4 | 606 Million USD | -17.1% |
| 1993 Q3 | 749 Million USD | -9.19% |
| 1993 Q1 | 787 Million USD | 35.22% |
| 1993 Q2 | 805 Million USD | 2.29% |
| 1992 Q4 | 582 Million USD | -17.91% |
| 1992 FY | - USD | 4.86% |
| 1992 Q3 | 709 Million USD | -7.56% |
| 1992 Q1 | 725 Million USD | 24.78% |
| 1992 Q2 | 767 Million USD | 5.79% |
| 1991 Q2 | 726 Million USD | 0.0% |
| 1991 FY | - USD | 0.76% |
| 1991 Q1 | 726 Million USD | 1.82% |
| 1991 Q4 | 581 Million USD | -6.44% |
| 1991 Q3 | 621 Million USD | -14.46% |
| 1990 FY | - USD | 26.57% |
| 1990 Q3 | 536 Million USD | -30.57% |
| 1990 Q1 | 771 Million USD | 59.63% |
| 1990 Q4 | 713 Million USD | 33.02% |
| 1990 Q2 | 772 Million USD | 0.13% |
| 1989 Q4 | 483 Million USD | -12.02% |
| 1989 FY | - USD | 22.48% |
| 1989 Q2 | 2.39 Billion USD | 335.34% |
| 1989 Q1 | 549 Million USD | 110.17% |
| 1989 Q3 | 549 Million USD | -77.03% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbbVie Inc. | 26.35 Billion USD | 9.989% |
| Bristol-Myers Squibb Company | 19.41 Billion USD | -22.187% |
| Bristol-Myers Squibb Company Ce | 19.41 Billion USD | -22.187% |
| Eli Lilly and Company | 8.56 Billion USD | -176.909% |
| Merck & Co., Inc. | 6.9 Billion USD | -243.492% |
| Novartis AG | 18.28 Billion USD | -29.744% |
| Organon & Co. | 1.43 Billion USD | -1552.159% |
| Pfizer Inc. | 9.55 Billion USD | -148.247% |